Indegene Ltd.

Financial

	Indegene	Syngene Internation.	Jubilant Pharmova
Operational Metrics
Software Services
Active Clients	63.0 .	n/a	n/a
Financials
5 yr Average ROE	24.44 %	14.02 %	8.35 %
5yr average Equity Multiplier	0.36	1.65	2.0
5yr Average Asset Turnover Ratio	1.26	0.51	0.59
5yr Avg Net Profit Margin	9.78 %	16.68 %	7.13 %
Price to Book	5.12	5.35	2.4
P/E	32.93	50.97	22.76
5yr Avg Cash Conversion Cycle	90.91 Days	-1572.22 Days	-19.21 Days
Inventory Days	0.0	17.83 Days	81.78 Days
Days Receivable	90.91 Days	50.73 Days	51.11 Days
Days Payable	0.0	-1569.1 Days	173.51 Days
5yr Average Interest Coverage Ratio	21.14	16.65	3.98
5yr Avg ROCE	38.04 %	14.42 %	9.05 %
5yr Avg Operating Profit Margin	20.03 %	29.32 %	18.69 %
5 yr average Debt to Equity	-0.71	0.2	0.64
5yr CAGR Net Profit	n/a	4.36 %	-38.8 %
5yr Average Return on Assets	12.9 %	8.45 %	4.23 %
Shareholdings
Promoter Holding	0.0	52.74 %	50.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-17.67 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.37 %	14.6 %	3.61 %

Business

	Indegene	Syngene Internation.	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Enterprise Commercial Solutions 59.03 Enterprise Medical Solutions 23.2 Omnichannel Activation 12.33 CDMO 0 Discovery Services 0 Dedicated Centres 0 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Others 5.44	Product Wise Break-Up Discovery Services 0 0 Allergy therapy products 0 Radiopharmaceuticals 0 Dedicated Centres 0 Active pharmaceutical ingredients 0 Omnichannel Activation 0 Contract Research & Contract Manufacturing (CRAMS) 96.59 India Branded pharmaceuticals 0 Life science chemicals 0 CDMO 0 Solid dosage formulations 0 Specialty intermediates 0 Enterprise Commercial Solutions 0 Nutritional products 0 Enterprise Medical Solutions 0 0 Others 3.41	Product Wise Break-Up Discovery Services 0 Contract Manufacturing 16.81 Anti-allergic 10.21 Radiopharmaceuticals 44.9 Dedicated Centres 0 Active Pharmaceutical Ingredient (API) 9.26 Omnichannel Activation 0 0 India branded pharmaceuticals 0.72 Life science chemicals 0 CDMO 0 Solid dosage formulations 10.82 Specialty intermediates 0 Enterprise Commercial Solutions 0 Nutritional products 0 Enterprise Medical Solutions 0 Contract Research and Development Services 6.7 Others 0.58
Location Wise Break-Up	Location Wise Break-Up North America 66.03 Europe 30.69 India 0.86 Rest of the World 0 Japan 0 USA 0 China 0 Americas and Europe 0 Others 2.42	Location Wise Break-Up North America 0 Europe 25.15 India 1.87 Japan 0 China 0 USA 64.66 Americas and Europe 0 Rest of the World 4.9 Others 3.42	Location Wise Break-Up North America 0 Europe 0 India 2.33 Japan 0 China 0 USA 0 Americas and Europe 90.17 Rest of the World 7.5
Operating Profit Break-Up	Operating Profit Break-Up Enterprise Commercial Solutions 65.21 Enterprise Medical Solutions 30.19 Omnichannel Activation 4.6 Generics 0 CDMO Sterile Injectables 0 Allergy Immunotherapy 0 Radiopharma 0 Proprietary Novel Drugs 0 Contract Research and Development 0 Life Science Ingredients 0 Pharmaceuticals 0	-	Operating Profit Break-Up Contract Research and Development 15.39 Allergy Immunotherapy 20.39 Pharmaceuticals 0 Generics 8.2 Omnichannel Activation 0 CDMO Sterile Injectables 14.56 Life Science Ingredients 0 Enterprise Commercial Solutions 0 Proprietary Novel Drugs 0 Enterprise Medical Solutions 0 Radiopharma 41.47
Verticals	Verticals BioPharmaceuticals 93.4 Medical Devices Companies 3.2 Emerging biotech Companies 2.7 Others 0.7	-	-

Indegene Ltd.

SIGN UP FOR FREE